跳至主要内容
临床试验/CTRI/2019/07/020437
CTRI/2019/07/020437尚未招募未知

Assessment of efficacy, patient satisfaction & stereopsis in patients opting for Small Incision Lenticule Extraction (SMILE) monovision

Carl ZEISS India0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Age >=40 yearsâ?¨
  • 2. Myopia 1.0D to 10 D â?¨
  • 3. Refractive cylinder -4.00 DCL or less. â?¨
  • 4. Best spectacle corrected visual acuity (BSCVA) of 6/9 or better in each eye â?¨
  • 5. Stable refraction with less than -0.50D spherical or cylindrical error change in last one year.â?¨
  • 6. Contact lens wearers must have removed contact lenses at least two (2) weeks before the baseline measurement.
  • 7. No evidence of irregular astigmatism on corneal topography. â?¨
  • 8. Available to attend post-operative examinations for a 12-month period.
  • 9. Near Add > 0DSâ?¨

排除标准

  • 1. Progressive or unstable myopia and/or astigmatism.â?¨
  • 2. Clinical or corneal topographic evidence of keratoconus.â?¨
  • 3. A residual stromal bed thickness that is less than 275 microns from the corneal endothelium.
  • 4. Residual, recurrent or active ocular disease such as uveitis, severe dry eyes, severe allergic eye disease, glaucoma, visually significant cataract andâ?¨retinal disease.â?¨
  • 5. Previous corneal surgery or trauma.â?¨
  • 6. Taking systemic medications likely to affect wound healing, such as corticosteroids and antimetabolites.â?¨
  • 7. Systemically immunocompromised.â?¨
  • 8. Systemic disease likely to affect wound healing, such as diabetes, connective tissue disease and severe atopy.â?¨
  • 9.Pregnant or nursing.
  • 10. Use of Prisms
  • 11. Manifest Squint
  • 12.History of Corrected Strabismus
  • 13.Subnormal stereoacuity ( >60 Seconds of Arc)

研究者

发起方
Carl ZEISS India

相似试验